Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials

BACKGROUND: Treatment-resistant depression (TRD) is common and potentially life-threatening in adults, and the benefits and risks of adjunctive aripiprazole in these patients remain controversial. Therefore, we conducted a meta-analysis of randomized controlled trials (RCTs) to assess the efficacy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Luan, Shuxin, Wan, Hongquan, Zhang, Lei, Zhao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810518/
https://www.ncbi.nlm.nih.gov/pubmed/29445284
http://dx.doi.org/10.2147/NDT.S156619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810518/
https://www.ncbi.nlm.nih.gov/pubmed/29445284
http://dx.doi.org/10.2147/NDT.S156619

Ejemplares similares